ISRCTN16842454进行中（未招募）未知
Efficacy and safety of convalescent plasma transfusion administered as adjunctive treatment to standard treatment in moderate, severe, and/or critically ill patients with COVID-19
Ministry of Research and Technology/National Research and Innovation Agency (Kementerian Riset dan Teknologi Republik Indonesia)0 个研究点目标入组 5 人开始时间: 2020年11月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Confirmed COVID-19
- •2. Clinically moderate, severe, and/or critically ill
排除标准
- •1. History of allergy to plasma
- •2. Patient with an estimated poor prognosis with sofa score >11, risk of mortality 53%
研究者
相似试验
招募中
2 期
Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patientsIRCT20200406046968N2Tabriz University of Medical Sciences30
Unknown
3 期
Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19Covid19Immuno-DeficiencyOld Age DebilityNCT04836260University Hospital, Geneva100
已完成
2 期
Effect of convalescent plasma in COVID-19 patientsCTRI/2020/04/024706Institute of Liver and Biliary Sciences29
已完成
早期 1 期
Convalescent Plasma for COVID-19 PatientsCOVID 19NCT04516954Vinmec Research Institute of Stem Cell and Gene Technology4
已完成
3 期
Effect of convalescent plasma in COVID-19 patientsCTRI/2020/06/025803Institute of Liver and Biliary Sciences400